Securitas Capital Markets Day, March 7, 2024 – Save the date
STOCKHOLM, Oct. 27, 2023 /PRNewswire/ — Securitas is pleased to invite investors, analysts and financial media to our Capital Markets Day on Thursday March 7, 2024, at 14.00 CET to approximately 17.00. The event will provide a strategic and financial update. The event will take place at Securi
UGRO CAPITAL ANNOUNCES FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30th SEPTEMBER 2023
Reports AUM of INR 7,592 Cr, up 74% and PAT of INR 54.1 Cr up 329% (YoY) Advances on its Journey of Creating the Largest Small Business Financing Institution Driven by Data and Technology Key Highlights Disbursement of INR 4,543 in H1’24, up 51% and INR 2,506 Cr in Q2’24, up 23% QoQ.AU
Trip.com Celebrates 6th Anniversary with Enhanced Loyalty Program
Members can now enjoy better rewards and perks, up to 20% off hotels SINGAPORE, Oct. 27, 2023 /PRNewswire/ — Leading global travel service provider Trip.com is pleased to announce its 6th anniversary with a gift to its valued customers – an enhanced loyalty program that features a renewed me
CONVENING NOTICE – EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)
LUND, SWEDEN, Oct. 27, 2023 /PRNewswire/ — Immunovia AB (publ), reg. no. 556730-4299 (the “Company”), hereby gives notice that an extraordinary general meeting will take place on Tuesday 21st November 2023 at 10.00 in the Company’s offices at Medicon Village, Scheeletorget 1
Biotechnology reagents market size to increase by USD 36.01 billion | the high usage of biotechnology reagents in diagnostic and therapeutic applications drives market growth- Technavio
NEW YORK, Oct. 27, 2023 /PRNewswire/ — The Biotechnology Reagents Market by Technology, Application, and Geography – Forecast and Analysis 2023-2027 report has been published by Technavio. Market size is forecast to grow by USD 36,019.44 million between 2022 and 2027 at a CAGR of 7.51
Preem AB : Interim Report Third Quarter ended 30 September 2023
STOCKHOLM, Oct. 27, 2023 /PRNewswire/ — Preem delivered the strongest quarter so far this year powered by a strong performance in the Supply & Refining segment. The result was primarily driven by very strong international refining margins due to more favourable market conditions. The resul
Fagerhult Group AB Interim Report Q3 January-September 2023
STOCKHOLM, Oct. 27, 2023 /PRNewswire/ — The third quarter: Order intake was MSEK 2,026 (1,891), an increase of +7.1% adjusted to +0.8% for currency effects of MSEK +125 and business closures of MSEK -5Net sales were MSEK 2,079 (2,081), a decrease of -0.1% adjusted to -4.0% for currency effects
New Drug Application Approval by the Pharmaceutical Administration Bureau of Macau for Nefecon® for the Treatment of Primary IgA Nephropathy
STOCKHOLM, Oct. 27, 2023 /PRNewswire/ — Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that its commercial partner Everest Medicines (HKEX 1952.HK) (“Everest”) received approval from the Pharmaceutical Administration B
Software Testing Market to grow by USD 15.94 billion from 2022 to 2027, Growth driven by the rise in test automation services – Technavio
NEW YORK, Oct. 27, 2023 /PRNewswire/ — The “software testing market by service (functional, digital testing, and specialized offering), end-user (BFSI, telecom and media, manufacturing, retail, and others), and geography (North America, Europe, APAC, South America, and Middle East and A
THE ESTÉE LAUDER COMPANIES LAUNCHES 2023 BREAST CANCER CAMPAIGN BEAUTIFULLY UNITED TO HELP END BREAST CANCER
Together, The Estée Lauder Companies’ Breast Cancer Campaign and The Estée Lauder Companies Charitable Foundation have funded more than $118 million for lifesaving global research, education and access to medical services. NEW DELHI, Oct. 27, 2023 /PRNewswire/ — For more than 30 years
